News
MedPage Today on MSN21h
Nasal Powder for Acute Migraine Gets FDA NodThe FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback